BB

Bheemanna Boya Nagaladinne

Active Director Director DIN 10946168
DIN 10946168 First appointment Feb 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bheemanna Boya Nagaladinne

Data last updated:

Bheemanna Boya Nagaladinne is a Director at Bioscrip Pharmaceuticals Private Limited (since 2025). The company operates in Chemicals.

DIN 10946168
Primary Designation Director
Industry Chemicals
First Appointment 13 Feb 2025
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20252022Active

Board colleagues of Bheemanna Boya Nagaladinne

Directorship timeline

Open interactive timeline →
Bioscrip Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bheemanna Boya Nagaladinne

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bheemanna Boya Nagaladinne

Bheemanna Boya Nagaladinne currently holds 1 directorship: Bioscrip Pharmaceuticals Private Limited (Director, since 13 Feb 2025).

Bheemanna Boya Nagaladinne was first appointed on 13 Feb 2025 as Director at Bioscrip Pharmaceuticals Private Limited.

The current boards of Bheemanna Boya Nagaladinne's companies include Gayathri (Bioscrip Pharmaceuticals Private Limited), Harijana Gangadhar (Bioscrip Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available